Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Calamos L/S Equity: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Calamos L/S Equity (NASDAQ:CPZ).

Calamos Global Dynamic's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Calamos Global Dynamic's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Calamos Global Dynamic (NASDAQ:CHW).

Popular Teen Star Exits Will Smith Movie: Is It Related To Oscars Slap?

Popular Teen Star Exits Will Smith Movie: Is It Related To Oscars Slap?

The slap heard around the world has put a dark cloud over actor Will Smith and has movie studios now questioning what to do with the movies they have in the works to which he is attached. Another movie now faces trouble after losing a co-star and the studio.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Origin Agritech Stock Is Surging

Origin Agritech Ltd (NASDAQ: SEED) shares are trading higher Thursday after the company announced it signed purchase agreements to sell two feedstock companies 50,000 metric tons of its corn for RMB150 million ($23.58 million).

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has

Chart Wars, Twitter Vs. Meta Platforms: How Has Elon Musk's Role As Shareholder Influenced Stock Price?

Meta Platforms, Inc (NASDAQ: FB) and Twitter, Inc (NYSE: TWTR) were trading flat on Thursday morning, in tandem with the general markets, which were consolidating Wednesday's steep sell-off.

Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis

In its SEC filing, Seres Therapeutics Inc (NASDAQ: MCRB) disclosed it would not move forward with the planned SER-301 Phase 1b second study cohort. In its Q4 earnings release, Seres said that SER-301 was safe to proceed to the placebo-controlled second cohort in a Phase Ib trial even though outcome data from the…

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Analyzing Advent Technologies Holdings Inc. - Class A Common Stock's Short Interest

Analyzing Advent Technologies Holdings Inc. - Class A Common Stock's Short Interest

Advent Technologies Holdings Inc. - Class A Common Stock's (NASDAQ:ADN) short percent of float has fallen 13.5% since its last report. The company recently reported that it has 4.24 million shares sold short, which is 16.15% of all regular shares that are available for trading.

Karat Packaging Forms JV To Build New Factory In Taiwan

Karat Packaging Forms JV To Build New Factory In Taiwan

Karat Packaging Inc (NASDAQ:KRT) has entered a definitive joint venture agreement with Happiness Moon Co. Ltd. to establish a new corporation, Green Earth Technology, to build a new 180,000 square-foot factory in Taiwan. Karat will hold a 49% interest in Green Earth, with an initial investment of ~$6 million. The new facility will…

Byrna Technologies's Return On Capital Employed Insights

Byrna Technologies's Return On Capital Employed Insights

Byrna Technologies (NASDAQ:BYRN) brought in sales totaling $7.98 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 0.41%, resulting in a loss of $3.22 million.

Looking Into Simply Good Foods's Return On Capital Employed

Looking Into Simply Good Foods's Return On Capital Employed

Pulled from Benzinga Pro data, Simply Good Foods (NASDAQ:SMPL) showed a loss in earnings since Q1, totaling $18.46 million. Sales, on the other hand, increased by 5.49% to $296.72 million during Q2.

Looking Into Biocept's Return On Capital Employed

Looking Into Biocept's Return On Capital Employed

Benzinga Pro data, Biocept (NASDAQ:BIOC) reported Q4 sales of $13.98 million. Earnings fell to a loss of $2.97 million, resulting in a 375.6% decrease from last quarter.

Looking Into Schnitzer Steel Indus's Return On Capital Employed

Looking Into Schnitzer Steel Indus's Return On Capital Employed

Pulled from Benzinga Pro data, Schnitzer Steel Indus (NASDAQ:SCHN) posted Q2 earnings of $38.16 million, an increase from Q1 of 19.27%. Sales dropped to $783.20 million, a 1.87% decrease between quarters.

Get all your
news in one place.

100's of premium titles.
One news app.

Disney To Air PSA Supportive Of Transgender Youth

Walt Disney Co. (NYSE: DIS) is offering another sign of its support for the LGBTQ community by airing a new public service announcement showing support for transgender youth.

What To Focus On Now After Tilray's Q3 Earnings Report, Analyst Shares Main Takeaways

On Wednesday, Tilray Brands, Inc. (NASDAQ:TLRY) reported financial results for the third fiscal quarter ended Feb. 28, 2022, with net revenue up 23% from the same quarter last year, reaching $152 million.

Yoshitsu Looks To Reduce Logistics Costs Via Warehouse Partnership With Lion Group

Japanese beauty and health products retailer Yoshitsu Co Ltd (NASDAQ:TKLF) has partnered with two cross-border E-commence, warehousing, and logistics companies, Hainan Lion and LHK, collectively called the Lion Group. Yoshitsu has modified and amended its service agreement with Lion Group to optimize international warehouse operations for expanding its business presence in China. Under the…

Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the

Get all your
news in one place.

100's of premium titles.
One news app.

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

Gainers Cazoo Gr (NYSE:CZOO) stock moved upwards by 11.1% to $3.2 during Thursday's pre-market session. The company's market cap stands at $2.4 billion. As per the press release, Q4 earnings came out today.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.

12 Industrials Stocks Moving In Thursday's Pre-Market Session

Gainers Momentus (NASDAQ:MNTS) stock rose 32.9% to $3.92 during Thursday's pre-market session. The company's market cap stands at $318.3 million.

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Gainers Conduent (NASDAQ:CNDT) stock moved upwards by 13.4% to $5.51 during Thursday's pre-market session. The market value of their outstanding shares is at $1.1 billion.

Mid-Morning Market Update: Markets Mixed; US Jobless Claims Fall Last Week

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 150 points on Thursday.

Primoris Services Pockets Over $155M In Energy/Renewables Segment Contracts

Primoris Services Corp (NASDAQ:PRIM) has secured two projects with a combined value of more than $155 million. The awards were secured by the company's Energy/Renewables Segment in Texas and Florida. Texas Department of Transportation awarded the Heavy Civil contract, valued at more than $48 million. The project will commence in 2Q22 and…

Apogee Enterprises Q4 Results Surpass Estimates, Provides FY23 Guidance

Apogee Enterprises Inc (NASDAQ:APOG) reported fourth-quarter sales growth of 6.3% year-over-year to $327.96 million, beating the consensus of $323.33 million. Revenue by segments: Architectural Framing Systems $143.13 million (+9% Y/Y); Architectural Glass $72.55 million (-12% Y/Y); Architectural Services $98.73 million (+21% Y/Y); and Large-Scale Optical $26.55 million (+23% Y/Y). Adjusted EPS improved…

1 … 718 719 720 721

People

Jada Pinkett Smith

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

366,520 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play